118 related articles for article (PubMed ID: 25033684)
1. [Ultrasound semiotics in recurrent ovarian cancer after optimal cytoreductive surgery].
Baklanova NS; Kolomiets LA; Frolova IG; Viatkina NV; Krasil'nikov SÉ
Vopr Onkol; 2014; 60(3):323-6. PubMed ID: 25033684
[TBL] [Abstract][Full Text] [Related]
2. Peritonectomy and hyperthermic chemotherapy in patients with advanced or recurrent ephitelial ovarian cancer: a single center cohort study.
Massari R; Barone M; Basilico R; Carella C; Colasante A; De Tursi M; Filippone A; Guetti L; Mani A
Minerva Chir; 2014 Feb; 69(1):17-26. PubMed ID: 24675243
[TBL] [Abstract][Full Text] [Related]
3. Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Robella M; Vaira M; Marsanic P; Mellano A; Borsano A; Cinquegrana A; Sottile A; De Simone M
Minerva Chir; 2014 Feb; 69(1):27-35. PubMed ID: 24675244
[TBL] [Abstract][Full Text] [Related]
4. Indication for oophorectomy during cytoreduction for intraperitoneal metastatic spread of colorectal or appendiceal origin.
Evers DJ; Verwaal VJ
Br J Surg; 2011 Feb; 98(2):287-92. PubMed ID: 21046680
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive surgery for ovarian cancer.
Kecmanovic DM; Pavlov MJ; Kovacevic PA; Ceranic MS; Stamenkovic AB
Eur J Surg Oncol; 2003 May; 29(4):315-20. PubMed ID: 12711282
[TBL] [Abstract][Full Text] [Related]
6. Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: is there a case for thoracic cytoreduction?
Perri T; Ben-Baruch G; Kalfon S; Beiner ME; Helpman L; Hogen LB; Shapira-Frommer R; Korach J
Gynecol Oncol; 2013 Oct; 131(1):27-31. PubMed ID: 23880152
[TBL] [Abstract][Full Text] [Related]
7. Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with primary and recurrent advanced ovarian cancer.
Cascales Campos P; Gil J; Parrilla P
Eur J Surg Oncol; 2014 Aug; 40(8):970-5. PubMed ID: 24035502
[TBL] [Abstract][Full Text] [Related]
8. Ovarian psammocarcinoma with peritoneal implants.
Cobellis L; Pezzani I; Cataldi P; Bome A; Santopietro R; Petraglia F
Eur J Obstet Gynecol Reprod Biol; 2003 Apr; 107(2):217-9. PubMed ID: 12648875
[TBL] [Abstract][Full Text] [Related]
9. [Surgical strategy for peritoneal carcinosis of ovarian origin].
Michel G; Morice P; Castaigne D; Lanoux P
J Chir (Paris); 1997 Nov; 134(5-6):229-32. PubMed ID: 9772978
[TBL] [Abstract][Full Text] [Related]
10. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.
Zivanovic O; Eisenhauer EL; Zhou Q; Iasonos A; Sabbatini P; Sonoda Y; Abu-Rustum NR; Barakat RR; Chi DS
Gynecol Oncol; 2008 Feb; 108(2):287-92. PubMed ID: 17996927
[TBL] [Abstract][Full Text] [Related]
11. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
[TBL] [Abstract][Full Text] [Related]
12. Cytoreductive surgery combined with organ resection for advanced ovarian carcinoma.
Todo Y; Sakuragi N; Oikawa M; Negishi H; Yamamoto R; Yoshiaki K; Tsumura N; Kawaguchi I; Fujimoto S
Int J Clin Oncol; 2003 Apr; 8(2):90-6. PubMed ID: 12720101
[TBL] [Abstract][Full Text] [Related]
13. [Primary peritoneal carcinoma: a report of two cases and a review of the literature].
Popovska S; Veselinova T; Gorchev G; Tomov S; Elenchev L
Akush Ginekol (Sofiia); 2005; 44(1):8-10. PubMed ID: 15853004
[TBL] [Abstract][Full Text] [Related]
14. Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer.
Chang SJ; Bristow RE; Ryu HS
Ann Surg Oncol; 2012 Dec; 19(13):4059-67. PubMed ID: 22766983
[TBL] [Abstract][Full Text] [Related]
15. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT.
Kim CK; Park BK; Choi JY; Kim BG; Han H
J Comput Assist Tomogr; 2007; 31(6):868-75. PubMed ID: 18043348
[TBL] [Abstract][Full Text] [Related]
16. Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy.
Esselen KM; Rodriguez N; Growdon W; Krasner C; Horowitz NS; Campos S
Gynecol Oncol; 2012 Oct; 127(1):51-4. PubMed ID: 22659193
[TBL] [Abstract][Full Text] [Related]
17. Perioperative fast track program in intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery in advanced ovarian cancer.
Cascales Campos PA; Gil Martínez J; Galindo Fernández PJ; Gil Gómez E; Martínez Frutos IM; Parrilla Paricio P
Eur J Surg Oncol; 2011 Jun; 37(6):543-8. PubMed ID: 21489742
[TBL] [Abstract][Full Text] [Related]
18. CT findings of primary extra-intestinal gastrointestinal stromal tumor of greater omentum with extensive peritoneal and bilateral ovarian metastases.
Jindal G; Rastogi R; Kachhawa S; Meena GL
Indian J Cancer; 2011; 48(1):135-7. PubMed ID: 21330768
[No Abstract] [Full Text] [Related]
19. Surveillance for the detection of recurrent ovarian cancer: survival impact or lead-time bias?
Tanner EJ; Chi DS; Eisenhauer EL; Diaz-Montes TP; Santillan A; Bristow RE
Gynecol Oncol; 2010 May; 117(2):336-40. PubMed ID: 20153027
[TBL] [Abstract][Full Text] [Related]
20. The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC).
Cheng X; Jiang R; Li ZT; Tang J; Cai SM; Zhang ZY; Tian WJ; Zang RY
Eur J Surg Oncol; 2009 Oct; 35(10):1105-8. PubMed ID: 19443175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
